Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 126K | $14.9M | $118.50 | Mar 1, 2024 | Direct |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 58.9K | Feb 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | Feb 29, 2024 | 2 | -$1.18M | 4 | Mar 4, 2024 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 21, 2024 | 2 | $0 | 4 | Feb 23, 2024 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 2 | -$1.01M | 4 | Mar 2, 2023 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 2 | -$1.47M | 4 | Mar 2, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Dec 23, 2021 | 5 | -$5.89M | 4 | Dec 28, 2021 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Dec 13, 2021 | 6 | -$5.6M | 4 | Dec 15, 2021 | EXECUTIVE VICE PRESIDENT |